Latest Updates

The BIRAC AcE Fund aims to accelerate growth of biotech startups

The regulator is working on a global policy that would reward firms which strive for higher quality of drugs

Lacosamide tablets are the generic equivalent of USB's Vimpat tablets and used in the treatment of partial-onset seizures in…

In 2013, the USFDA had issued an import alert on the company's Aurangabad-based Waluj and Chikalthana facilities

The use of combination targeted therapies will improve progression-free disease as well as survival rates

Willing to collaborate with Indian regulators, other stakeholders: US FDA

In both the PINNACLE 1 and PINNACLE 2 studies, the primary objective was to assess benefits on lung function as measured by trough…

Through this acquisition, combined business of both the entities would become the second largest hospital generic player in Spain

Is the first company in India to manufacture the goat pox vaccine

A novel oral treatment regimen for patients suffering from Hepatitis C

Only 98 of the 178 Jan Aushadhi stores are functional

PD will become a wholly-owned subsidiary of Lupin, subject to closing conditions

The shares were listed at Rs 523.95 per share

The patents from the US and New Zealand are valid until 2030 and 2031

IPM valued at Rs 89,244 crores

Discussions were held to understand key regulatory issues related to excipients

To sign an MoU between the US FDA and the Export Inspection Council of India

Discussions will be held on opportunities for growth, challenges and way forward

The company has received approval for generic sofosbuvir tablets in the strength of 400 mg from Drugs Controller General (India)

Makes Rs 26-crore payments towards TDS, PF